Visilizumab induces apoptosis of mucosal T lymphocytes in ulcerative colitis through activation of caspase 3 and 8 dependent pathways
Visilizumab, a humanized low-Fc receptor binding anti-CD3 antibody, induces rapid clinical response in patients with steroid-refractory ulcerative colitis (UC). Several effective treatments in IBD have been linked to the induction of mucosal T cell apoptosis. The aim of the present study was to eval...
Ausführliche Beschreibung
Bibliographische Detailangaben
Veröffentlicht in: | Clinical immunology (Orlando, Fla.). - 1999. - 127(2008), 3 vom: 01. Juni, Seite 322-9
|
1. Verfasser: |
Yu, Qi T
(VerfasserIn) |
Weitere Verfasser: |
Saruta, Masayuki,
Papadakis, Konstantinos A |
Format: | Online-Aufsatz
|
Sprache: | English |
Veröffentlicht: |
2008
|
Zugriff auf das übergeordnete Werk: | Clinical immunology (Orlando, Fla.)
|
Schlagworte: | Journal Article
Antibodies, Monoclonal
Antibodies, Monoclonal, Humanized
Apoptosis Regulatory Proteins
CD3 Complex
Enzyme Inhibitors
Caspase 3
EC 3.4.22.-
Caspase 8
visilizumab
H18SKU3289 |